| scholarly article | Q13442814 |
| P2093 | author name string | Lei Wang | |
| Ying Yang | |||
| Junqi He | |||
| Duiping Feng | |||
| Zhiqiang Peng | |||
| Junfang Zheng | |||
| P2860 | cites work | PDZK1 is a novel factor in breast cancer that is indirectly regulated by estrogen through IGF-1R and promotes estrogen-mediated growth | Q37161525 |
| Altered metabolic pathways in clear cell renal cell carcinoma: A meta-analysis and validation study focused on the deregulated genes and their associated networks | Q38467844 | ||
| Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma. | Q38959456 | ||
| Renal cell carcinoma: management of advanced disease | Q40827792 | ||
| Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria | Q41726997 | ||
| Accuracy of the revised 2010 TNM classification in predicting the prognosis of patients treated for renal cell cancer in the north east of England | Q43467678 | ||
| Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort | Q44130026 | ||
| Increasing expression of fascin in renal cell carcinoma associated with clinicopathological parameters of aggressiveness | Q44605086 | ||
| The beta1-adrenergic receptor mediates extracellular signal-regulated kinase activation via Galphas | Q46225959 | ||
| Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up | Q46234210 | ||
| Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma | Q48508481 | ||
| EBP50 interacts with EGFR and regulates EGFR signaling to affect the prognosis of cervical cancer patients | Q51580124 | ||
| Renal Cell Carcinoma Recurrence After Nephrectomy for Localized Disease: Predicting Survival From Time of Recurrence | Q59571845 | ||
| Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up | Q72790365 | ||
| High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma | Q83880433 | ||
| EBP50 exerts tumor suppressor activity by promoting cell apoptosis and retarding extracellular signal-regulated kinase activity | Q22001537 | ||
| Identification and partial characterization of PDZK1: a novel protein containing PDZ interaction domains | Q24336372 | ||
| Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study | Q28249649 | ||
| Sustained proliferation in cancer: Mechanisms and novel therapeutic targets | Q28396388 | ||
| Proteomics. Tissue-based map of the human proteome | Q29617248 | ||
| Tetravalent antibody-scTRAIL fusion proteins with improved properties | Q33619046 | ||
| Increased expression of the very low-density lipoprotein receptor mediates lipid accumulation in clear-cell renal cell carcinoma | Q34489747 | ||
| Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer | Q34644894 | ||
| Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features | Q34866372 | ||
| Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis | Q35752074 | ||
| The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer | Q35753643 | ||
| Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes | Q35754655 | ||
| EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation | Q36319689 | ||
| MAGI3 negatively regulates Wnt/β-catenin signaling and suppresses malignant phenotypes of glioma cells. | Q36546491 | ||
| Influence of PDZK1 on lipoprotein metabolism and atherosclerosis | Q36708971 | ||
| Expression of CIDE proteins in clear cell renal cell carcinoma and their prognostic significance | Q36791761 | ||
| From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma | Q37154789 | ||
| P921 | main subject | renal cell carcinoma | Q1164529 |
| P304 | page(s) | 62-72 | |
| P577 | publication date | 2016-12-09 | |
| P1433 | published in | EBioMedicine | Q24912341 |
| P1476 | title | Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma | |
| P478 | volume | 15 |
| Q90589974 | Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): A critical step towards the personalized care of renal cancers |
| Q42197616 | Downregulation of PDZ Domain Containing 1 (PDZK1) is a Poor Prognostic Marker for Clear Cell Renal Cell Carcinoma |
| Q90593475 | Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma |
| Q93270317 | Long noncoding RNA PENG upregulates PDZK1 expression by sponging miR-15b to suppress clear cell renal cell carcinoma cell proliferation |
| Q61811485 | MiR-223-3p promotes cell proliferation and metastasis by downregulating SLC4A4 in clear cell renal cell carcinoma |
| Q38686603 | PDZK1 inhibits the development and progression of renal cell carcinoma by suppression of SHP-1 phosphorylation. |
| Q48119782 | SERPINH1 overexpression in clear cell renal cell carcinoma: association with poor clinical outcome and its potential as a novel prognostic marker |
Search more.